Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Closed
    Phase
    Published
    SWOG Clinical Trial Number
    SWOG-7204/7205

    Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance
    Research Committee(s)
    Lymphoma
    Activated
    04-17-1972
    Closed
    09-10-1974
    Closed
    Phase
    Published
    SWOG Clinical Trial Number
    SWOG-781

    Radiotherapy - Chemotherapy (MOPP) for Stages I and II, A and B Hodgkin's
    Activated
    02-14-1972
    Closed
    08-08-1978
    Closed
    Phase
    SWOG Clinical Trial Number
    SWOG-780

    Combination Cyclophosphamide, Vincristine, Prednisone and Bleomycin for Non-Hodgkin's Lymphoma
    Activated
    11-04-1971
    Closed
    02-08-1973
    Closed
    Phase
    Published
    SWOG Clinical Trial Number
    SWOG-774/775

    Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4)
    Activated
    07-20-1971
    Closed
    08-23-1974
    Closed
    Phase
    SWOG Clinical Trial Number
    SWOG-160

    Combined Radiotherapy and Chemotherapy for Stage II B, Stage III A and Stage III B Hodgkin's Disease
    Activated
    03-18-1971
    Closed
    02-21-1975
    Closed
    Phase
    Published
    SWOG Clinical Trial Number
    SWOG-440

    Bleomycin for Solid Tumors and Lymphomas
    Activated
    12-11-1970
    Closed
    07-01-1971
    Closed
    Phase
    Accrual
    91%
    SWOG Clinical Trial Number
    SWOG-438

    Combined 5-Fluorouracil (NSC-19893) and Hydrazine-1- Acetyl-2-Picolinoyl (NSC-68626) Therapy in the Treatment of Adenocarcinoma of the Stomach and Colon and Carcinoid
    Activated
    06-09-1970
    Closed
    06-15-1971
    Closed
    Phase
    Accrual
    53%
    SWOG Clinical Trial Number
    SWOG-437

    NSC-409962 ... 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Phase II study ... Advanced Breast Cancer
    Activated
    01-19-1970
    Closed
    Phase
    SWOG Clinical Trial Number
    SWOG-772/773

    Hodgkin's Disease: Remission Consolidation with Actinomycin D, Vinblastine, and Methotrexate (MOPP#3)
    Activated
    10-08-1969
    Closed
    11-09-1971
    Closed
    Phase
    Accrual
    1%
    SWOG Clinical Trial Number
    SWOG-229

    Study of Dibromomannitol in Chronic Granulocytic Leukemia
    Activated
    08-06-1969
    Closed
    Phase
    Accrual
    58%
    SWOG Clinical Trial Number
    SWOG-434

    Imidazole Carboxamide Dimethyl Triazene (NSC-45388) in Patients with Solid Tumors (Excluding Melanomas, Lymphomas, and Breast Cancer)
    Activated
    05-20-1969
    Closed
    06-24-1970
    Closed
    Phase
    Accrual
    9%
    SWOG Clinical Trial Number
    SWOG-431

    Evaluation of Bis-Chlorethyl-nitrosourea (BCNU) in Multiple Myeloma
    Research Committee(s)
    Myeloma
    Activated
    04-16-1969
    Closed
    Phase
    Accrual
    0%
    SWOG Clinical Trial Number
    SWOG-227

    Protocol for Phase II Trial of Actinomycin D & Vincristine in Lung Cancer
    Activated
    08-06-1968
    Closed
    08-21-1969
    Closed
    Phase
    Accrual
    4%
    SWOG Clinical Trial Number
    SWOG-717

    Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults
    Activated
    07-29-1968
    Closed
    Phase
    SWOG Clinical Trial Number
    SWOG-756/759

    Combination Chemotherapy in Advanced Hodgkin's Disease: Induction and Maintenance of Remission
    Activated
    09-29-1967
    Closed
    09-01-1973
    Closed
    Phase
    Accrual
    93%
    SWOG Clinical Trial Number
    SWOG-703

    Combination for Cyclophosphamide (NSC-26271), Vincristine (NSC-67574) and 5-Fluorouracil (NSC-19893) in the Treatment of Advanced Breast Cancer
    Activated
    07-21-1967
    Closed
    Phase
    Accrual
    100%
    SWOG Clinical Trial Number
    SWOG-226

    Phase II Protocol for Porfiromycin Solid Tumors
    Activated
    07-12-1967
    Closed
    Phase
    Accrual
    2%
    SWOG Clinical Trial Number
    SWOG-427

    Cytosine Arabinoside (NSC-63878) in Acute Leukemia in Adults
    Activated
    07-01-1967
    Closed
    06-09-1969
    Closed
    Phase
    Published
    SWOG Clinical Trial Number
    SWOG-8264

    Combination Chemotherapy with m-AMSA, Cis-Platinum and MGBG for Refractory Lymphoma
    Activated
    08-11-1962
    Closed
    03-16-1984
    Closed
    Phase
    Accrual
    6%
    SWOG Clinical Trial Number
    SWOG-200

    Plan for a Cooperative Study in the Evaluation of the Effectiveness of Chemotherapeutic Agents in the Treatment of a Broadspectrum of Malignant Diseases in Adults
    Activated
    06-23-1961